CYDYCytoDyn Inc

$0.2987
$0.0063
(2.15%)
Today
Updated: 03:58 PM EDT
EarningsJul 23
Mkt Cap$399.43M
Vol1.23M

About

CytoDyn, Inc. is a clinical-stage biotechnology company, which focuses on the clinical development of innovative treatments for multiple therapeutic indications based on its product candidate, leronlimab, a novel humanized monoclonal antibody targeting the C-C chemokine receptor type 5. Its pipeline includes Leronlimab Clinical Development Pipeline and Long-Acting CCR5 Inhibitor Development Pipeline. The company was founded by Allen D. Allen on May 2, 2002 and is headquartered in Vancouver, WA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
13

Frequently Asked Questions

What is Market Cap of Cytodyn Inc?
What is the 52-week high for Cytodyn Inc?
What is the 52-week low for Cytodyn Inc?
What is Cytodyn Inc stock price today?
What was Cytodyn Inc stock price yesterday?
What is the PE ratio of Cytodyn Inc?
What is the Price-to-Book ratio of Cytodyn Inc?
What is the 50-day moving average of Cytodyn Inc?
How many employees does Cytodyn Inc have?

Advertisement|Remove ads.